Professor Axel Behrens' team uses a combination of sophisticated genetics and human cancer organoids to understand the biology of cancer and to develop novel therapeutic options, with on emphasis an pancreatic cancer.
Professor Axel Behrens is a well-known international expert in cancer stem cell biology as well as a pioneer in forging partnerships between scientists from different disciplines. He leads the Cancer Stem Cell Team at the ICR in parallel with heading up the Cancer Research UK Convergence Science Centre, a major strategic collaboration between the ICR and Imperial College London.